VRSY.F Stock Overview
VMS Rehab Systems, Inc. engages in generic drug and home healthcare businesses.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
VMS Rehab Systems, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -99.95% |
| 5 Year Change | -99.98% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| VRSY.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -2.2% | -3.7% |
| 1Y | n/a | 11.6% | 20.5% |
Return vs Industry: Insufficient data to determine how VRSY.F performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how VRSY.F performed against the US Market.
Price Volatility
| VRSY.F volatility | |
|---|---|
| VRSY.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.6% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: VRSY.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine VRSY.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | n/a | n/a | www.vmsrehabsystemsinc.com |
VMS Rehab Systems, Inc. engages in generic drug and home healthcare businesses. It develops and tests generic tadalafil products. The company also sells orthopedic wedge seat cushions for relieving the discomfort and/or pain caused by other lower body medical issues, including pilonidal disease, piles disease, and hemorrhoids to home healthcare retail networks in Canada.
VMS Rehab Systems, Inc. Fundamentals Summary
| VRSY.F fundamental statistics | |
|---|---|
| Market cap | US$111.00 |
| Earnings (TTM) | US$35.84k |
| Revenue (TTM) | US$55.33k |
0.0x
P/E Ratio0.0x
P/S RatioIs VRSY.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VRSY.F income statement (TTM) | |
|---|---|
| Revenue | CA$76.17k |
| Cost of Revenue | CA$87.26k |
| Gross Profit | -CA$11.09k |
| Other Expenses | -CA$60.43k |
| Earnings | CA$49.34k |
Last Reported Earnings
Dec 31, 2013
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did VRSY.F perform over the long term?
See historical performance and comparison